NEW YORK (TheStreet) -- CHANGE IN RATINGSAdvanced Micro ( AMD - Get Report) downgraded at Oppenheimer from Perform to Underperform. Orders could track lower in the second half of the year. Ann Taylor Stores ( ANN) upgraded at BofA/Merrill to the US1 List on rebounding female products and valuation. Maintain Buy rating and $30 price target. Best Buy ( BBY - Get Report) downgraded at Jefferies from Buy to Hold. $36 price target. Sales trends are eroding further, and the stock could become a value trap. Costco ( COST - Get Report) upgraded at UBS from Neutral to Buy. $63 price target. Sales have been strong and recent weakness has created a buying opportunity. Eaton Vance ( EV - Get Report) upgraded at JP Morgan. Rating raised to Neutral from Underweight. Price target raised to $30 from $28. 2010 EPS estimates raised to $1.50 from $1.45. Edwards Lifesciences ( EW) rated new Outperform at William Blair. Company can deliver above-average growth, aided by new products. Intel ( INTC) downgraded at Oppenheimer from Outperform to Perform. Supply appears to be catching up with demand. Janus Capital ( JNS) upgraded at JP Morgan. Rating raised to Neutral from Underweight. Price target raised to $9.50 from $8.50. 2010 EPS estimates raised to $0.59 from $0.57. Marvell Technology ( MRVL) downgraded at Oppenheimer from Outperform to Perform. PC and consumer demand could fall in the second half of the year. Myriad Genetics ( MYGN) downgraded at JP Morgan. Rating lowered to Neutral from Overweight. Price target lowered to $18 from $28. Maintains 2010 EPS estimates of $1.32. Norfolk Southern ( NSC) upgraded at JP Morgan. Rating raised to Overweight from Neutral. Maintains $68 price target and 2010 EPS estimates of $3.81. Stericycle ( SRCL) rated new Buy at Jefferies. $80 price target. Business mix is shifting toward higher-margin accounts. Texas Instruments ( TXN) upgraded at Oppenheimer from Perform to Outperform. $30 price target. Company is a large-cap defensive play.
Celgene ( CELG - Get Report) added to Top Picks Live at Citi on valuation and solid Revlimid sales. Maintain Buy rating. Convergys ( CVG) target lowered at UBS to $11. Macro concerns could weigh on the company's multiple. Neutral rating. Expedia ( EXPE) cut from Conviction Buy List at Goldman. Google is entering the travel market. Target also lowered to $24. Google ( GOOG) estimates, target reduced at RBC. Shares of GOOG now seen reaching $600. Estimates also cut, given the company's currency risk. Hansen Natural ( HANS) target upped at Stifel to $44. Channel checks show better sales trends for Monster energy drinks. Human Genome Sciences ( HGSI) added to Top Picks Live at Citi on strong expectations for Benlysta, Citigroup said. Maintain Buy rating. International Speedway ( ISCA) price target cut at Citi to $27 from $29 on lower ticket sales. Maintain Hold rating. Nordstrom ( JWN) estimates increased at Sterne Agee through 2011. Company is seeing better sales trends. Buy rating and $50 price target. Time Warner ( TWX) estimates raised at Credit Suisse. TWX 2011 and 2012 EPS estimates increased to $2.64 and $2.94, respectively. Higher ad growth forecasts. Maintain Outperform rating and $37 price target. Visa ( V) added to Conviction Buy List at Goldman. Company has limited exposure to Europe and relatively high leverage to the growing debit market. $93 price target. Exxon Mobil ( XOM) estimates raised, target cut at UBS. Shares of XOM now seen reaching $63. On the other hand, estimates were increased, after the closing of the XTO purchase. Neutral rating.